@MaryBschanck But it's OS that matters, not mOS. As long as the ORR is pushing 80% and not in the 60s as before, the GPS non-responders shouldn't be an issue in HR success.
@asalciunas975@JohnKincade The story about Dabo/B Kelly was funny, but be careful with comments that week 1 QBs didn't look good. Antonio Williams, Clemson's #1 WR and a #5-10 WR in the nation left hurt after 5 plays. You would be defending Hurts's stats if AJ left in a 1st Q.
@JohnMcEnroe What would you say to someone who yells out during your serve at a major? Total d-bag move and you know better, right? Nice job blurting out the Texas-OSU score with no warning during the Sinner match.
@phwarner@bioinvestor24 Didn't explain that well. In fact stuck to continue looking at 120. Remove that impossible arm and titrate to 4 weeks and the data likely would've sent this to 60+ today instead of dead money for 2 years.
@GilaMonstrum@MeadowCapital@Stukes58@pawcio2009 Agreed, oral data is the only item of value within 6 months for sure...and nobody knows what PPS effect that data will have, especially when everyone assumes it will be great.
@MeadowCapital@Stukes58@pawcio2009 I'm not looking for reasons as to potential revenue...looking for reasons to invest now vs in 6 to 12 months, other than "maybe buyout".
@MeadowCapital@Stukes58@pawcio2009 Okay, if you think over 2 years for product to market has zero impact, so be it. Whatever floats your boat. Data deserts abound.